An update from RWS (RWS) indicates revenue in the six months to 31 March decreased by 2.5 per cent at constant currencies to £172m. The language, intellectual property (IP) and ‘localisation’ specialist said some clients deferred projects in the second quarter and there was lower-than-expected activity in IP services and the life sciences division.
IC TIP:
Buy
at
463p
In recent days, the group has observed higher demand in Moravia and life sciences, as it helps with clinical trials for Covid-19 vaccines, translates more material and provides additional support for technology customers that are seeing more use of their social networking platforms during the pandemic.
